EMA recommends approval for advanced lung cancer agent ceritinibThe European Medicines Agency has recommended granting a conditional marketing authorisation for ceritinib (Zykadia) for ALK-positive non-small cell lung cancer in adults with advanced disease.…
Scientists use crowdfunding to boost research into LSD effects on the brain Scientists have turned to crowdfunding to support an imaging study showing the effects of LSD on the brain, the first to be conducted in the UK.…
Virus-mimicking TB may offer therapeutic opportunities A study shows that TB bacteria release a section of DNA, a virus-mimicking molecule called c-di-AMP, and its behaviour offers drug and vaccine possibilities.…
US FDA approves antibiotic combination with new beta-lactamase inhibitor The US Food and Drug Administration has approved a new intravenous antibacterial product, Avycaz, which contains ceftazidime and a new beta-lactamase inhibitor, avibactam.…
Genetic risk for coronary events linked to statin response Patients with high and intermediate genetic risk for coronary heart disease benefit more from statin therapy than patients at low genetic risk, researchers have shown.…
Researchers look to spider venom for new analgesics Scientists have identified a potent modulator of voltage-gated sodium (NaV) channels from spider venom, which could hold promise as a new analgesic.…
Contain eating to a 12-hour window to contain weightPamela Mason describes research that suggests eating in a confined window of time may help to reduce weight gain.…
Could a probiotic pill cure diabetes?Recent news stories have suggested that a new probiotic pill could cure both type 1 and type 2 diabetes. However, much more research is required before these claims can be substantiated, writes Pamela Mason.…
Rheumatologists want to see system in place to track efficacy and safety of biosimilar products The British Society of Rheumatology (BSR) wants patients to register with its evidence database to track the efficacy and long-term safety of new biosimilar products.…